Base de dados : MEDLINE
Pesquisa : C11.187 [Categoria DeCS]
Referências encontradas : 2873 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 288 ir para página                         

  1 / 2873 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27778449
[Au] Autor:Huynh N; Wang J; Vavvas D
[Ad] Endereço:Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
[Ti] Título:Dilated fundus exam and associated findings in spontaneous subconjunctival haemorrhage.
[So] Source:Acta Ophthalmol;95(5):e432-e433, 2017 08.
[Is] ISSN:1755-3768
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Doenças da Túnica Conjuntiva
Hemorragia Ocular
[Mh] Termos MeSH secundário: Fundo de Olho
Seres Humanos
[Pt] Tipo de publicação:LETTER; COMMENT
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180205
[Lr] Data última revisão:
180205
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE
[do] DOI:10.1111/aos.13309


  2 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29212473
[Au] Autor:Aaltonen V; Alavesa M; Pirilä L; Vesti E; Al-Juhaish M
[Ad] Endereço:Department of Ophthalmology, Turku University Hospital, PO Box 52, FIN-20521, Turku, Finland. vesa.aaltonen@tyks.fi.
[Ti] Título:Case report: bilateral Mooren ulcer in association with hepatitis C.
[So] Source:BMC Ophthalmol;17(1):239, 2017 Dec 06.
[Is] ISSN:1471-2415
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Mooren ulcer has been considered as an idiopathic autoimmune keratitis. However, it has been in some cases suggested to be associated with hepatitis C, although the evidence is very vague. CASE PRESENTATION: We present a case of a man who was diagnosed with a primary Mooren ulcer in his right eye. The eye became blind despite of intensive treatment with local medications and extensive surgical procedures. After 10 years, the patient was diagnosed with the same disease, now in his left, previously healthy eye. There was no history that would suggest a secondary Mooren ulcer, but a chronic hepatitis C infection was detected. Treatment was targeted against hepatitis C (ribavirin and interferon) in addition to immunosuppressive medical and surgical treatment which resulted in a full and more than 6 years lasting remission of the disease. CONCLUSIONS: Whether the immunomodulatory and immunosuppressive medication against hepatitis C was the key reason for the good results in the treatment of the second eye, remains elusive. The causality of hepatitis C with respect to the pathogenesis of Mooren ulcer on this patient remains open, but should be considered as one of the possible etiological factors of the disease.
[Mh] Termos MeSH primário: Úlcera da Córnea/virologia
Infecções Oculares Virais/complicações
Hepatite C/complicações
[Mh] Termos MeSH secundário: Idoso
Antivirais/uso terapêutico
Doenças da Túnica Conjuntiva/virologia
Seres Humanos
Interferon-alfa/uso terapêutico
Masculino
Polietilenoglicóis/uso terapêutico
Proteínas Recombinantes/uso terapêutico
Ribavirina/uso terapêutico
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antiviral Agents); 0 (Interferon-alpha); 0 (Recombinant Proteins); 30IQX730WE (Polyethylene Glycols); 49717AWG6K (Ribavirin); G8RGG88B68 (peginterferon alfa-2b)
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171226
[Lr] Data última revisão:
171226
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171208
[St] Status:MEDLINE
[do] DOI:10.1186/s12886-017-0633-x


  3 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28229604
[Au] Autor:Krcová I; Stanislavová M; Pesko K; Furdová A; Koller J
[Ti] Título:[AMNIOTIC MEMBRANE APPLICATIONS - OUR EXPERIENCE].
[Ti] Título:MOZNOSTI POUZITIA AMNIOVEJ MEMBRÁNY - NASE SKÚSENOSTI..
[So] Source:Cesk Slov Oftalmol;72(6):204-208, 2016.
[Is] ISSN:1211-9059
[Cp] País de publicação:Czech Republic
[La] Idioma:cze
[Ab] Resumo:INTRODUCTION: Amniotic membrane is the innermost part of the fetal and packaging for its exceptional qualities likes to be used in treating many ocular pathologies. Amniotic membrane has improved the ability to treat ocular surface disease. It has unique features like support conjunctival and corneal epithelialization. MATERIAL AND METHODS: Retrospective analysis of group patients who underwent amniotic membrane transplantation at the Department of Ophthalmology Faculty of Medicine and UN Bratislava in 2013-2015. We evaluated indications amniotic membrane transplantation, the percentage, the number of transplants and the number of failures and retransplantation of the membrane. RESULTS: In group of 71 patients (amniotic membrane covering defects of conjunctiva and cornea) male patients formed a slight predominance of males in the number of patients a slightly larger preponderance in 38 women (53.5 %) - 52 surgeries (59.09 %) and 33 male (46.5 %) in 36 interventions (40.91 %). The left eye was affected in 40 interventions (45.45 %), 48 interventions were on the right eye (54.54 %). The most common cause application of 30.68 % in 27 eyes was corneal ulcer, bullous keratopathy followed by the 11.36 % in 10 eyes, and the ulcer herpetic keratitis in 9.10 % in 8 eyes. Injury or vulnus penetrans 6.82 % in 6 eyes, ulcers caused by paresis n. facialis 6.82 % in 6 eyes and sicca syndrome 5.68 % in 5 eyes.In 2015 we applied amniotic membrane covering the defect of eyelids after trauma in one patient. CONCLUSION: Amniotic membrane is the appropriate treatment in a number of diseases of ocular surface when conservative methods of treatment fail. In corneal application can prevent the execution of more aggressive treatment, such as keratoplasty, or to soothe inflammation and keratoplasty is not performed as emergent, but elective.Key words: amniotic membrane transplantation, eye diseases.
[Mh] Termos MeSH primário: Âmnio/transplante
Doenças da Túnica Conjuntiva/cirurgia
Doenças da Córnea/cirurgia
Procedimentos Cirúrgicos Oftalmológicos
[Mh] Termos MeSH secundário: Adulto
Idoso
Feminino
Seres Humanos
Masculino
Meia-Idade
Reoperação
Estudos Retrospectivos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171128
[Lr] Data última revisão:
171128
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170224
[St] Status:MEDLINE


  4 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27860477
[Au] Autor:Mlcáková E; Mlcák P; Karhanová M; Langová K; Maresová K
[Ti] Título:[Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
[Ti] Título:Hodnocení ocního povrchu u pacientu lécených analogy prostaglandinu s ohledem na obsazenou konzervacní látku..
[So] Source:Cesk Slov Oftalmol;72(4):120-127, 2016.
[Is] ISSN:1211-9059
[Cp] País de publicação:Czech Republic
[La] Idioma:cze
[Ab] Resumo:PURPOSE: The aim of this study was to evaluate the ocular surface in patients treated with prostaglandin analogues considering contained preservative agent. METHODS: 60 patients with glaucoma or ocular hypertension treated with prostaglandin analogue monotherapy were enrolled in this observational study. 20 patients with glaucoma suspect or ocular hypertension without local or systemic glaucoma medication formed the control group. Demographic data and medical history were recorded for each participant. Patients filled in the Ocular surface disease index© (OSDI) questionnaire and underwent an ophthalmological examination including assessment of conjunctival hyperaemia according to Efron, tear film break up time (BUT) and fluorescein staining according to the Oxford grading scheme. Treated participants were divided into 3 groups according to the preservative contained in the currently used prostaglandin analogue: the preservative-free group (18 patients), the polyquaternium group (17 patients) and the benzalkonium chloride (BAK) group (25 patients). RESULTS: The control group had significantly lower fluorescein staining than the preservative-free group (p=0.001), the polyquaternium group (p=0.007) and the BAK group (p=0.002). The conjunctival hyperaemia was significantly lower in the preservative-free group compared to the polyquaternium group (p=0.011). There was no significant difference among the other groups. The difference neither in the OSDI score nor in the BUT was statistically important. CONCLUSION: This study confirmed that the ocular surface is worse in patients treated with prostaglandin analogue monotherapy than in people without glaucoma medication. A significant difference among treated patients depending on a preservative agent was not proved.Key words: benzalkonium chloride, glaucoma, ocular surface disease, preservatives, prostaglandin analogues.
[Mh] Termos MeSH primário: Anti-Hipertensivos/administração & dosagem
Doenças da Túnica Conjuntiva/prevenção & controle
Glaucoma de Ângulo Aberto/tratamento farmacológico
Hiperemia/prevenção & controle
Conservantes Farmacêuticos/administração & dosagem
Prostaglandinas F Sintéticas/administração & dosagem
[Mh] Termos MeSH secundário: Administração Tópica
Adulto
Idoso
Compostos de Benzalcônio/administração & dosagem
Compostos de Benzalcônio/efeitos adversos
Doenças da Túnica Conjuntiva/induzido quimicamente
Feminino
Fluorofotometria
Seres Humanos
Hiperemia/induzido quimicamente
Pressão Intraocular/efeitos dos fármacos
Masculino
Meia-Idade
Hipertensão Ocular/tratamento farmacológico
Soluções Oftálmicas
Polímeros/administração & dosagem
Polímeros/efeitos adversos
Conservantes Farmacêuticos/efeitos adversos
Inquéritos e Questionários
Adulto Jovem
[Pt] Tipo de publicação:COMPARATIVE STUDY; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antihypertensive Agents); 0 (Benzalkonium Compounds); 0 (Ophthalmic Solutions); 0 (Polymers); 0 (Preservatives, Pharmaceutical); 0 (Prostaglandins F, Synthetic); 75345-27-6 (polyquaternium 1)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171128
[Lr] Data última revisão:
171128
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161119
[St] Status:MEDLINE


  5 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28950941
[Au] Autor:Mizoguchi S; Iwanishi H; Arita R; Shirai K; Sumioka T; Kokado M; Jester JV; Saika S
[Ad] Endereço:Department of Ophthalmology, Wakayama Medical University, Wakayama, Japan.
[Ti] Título:Ocular surface inflammation impairs structure and function of meibomian gland.
[So] Source:Exp Eye Res;163:78-84, 2017 Oct.
[Is] ISSN:1096-0007
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Dysfunction of the meibomian glands alters secreted meibum quantitatively and qualitatively that can lead to damage to the ocular surface epithelium. In response to an unstable tear film cause by meibomian gland dysfunction, ocular surface epithelium is damaged and expresses inflammatory cytokines leading to secondary ocular inflammation. In turn, inflammatory disorders of the palpebral conjunctiva and lid margin may affect the structure and function of meibomian gland. The disorders include allergic conjunctivitis, long-term usage of contact lenses, dermatological diseases that affect conjunctival homeostasis, Stevens-Johnson's syndrome or chemical burning of the ocular surface and lid margin.
[Mh] Termos MeSH primário: Doenças da Túnica Conjuntiva/complicações
Epitélio Anterior/metabolismo
Doenças Palpebrais/complicações
Glândulas Tarsais/metabolismo
[Mh] Termos MeSH secundário: Lentes de Contato/efeitos adversos
Edema da Córnea/metabolismo
Citocinas/metabolismo
Seres Humanos
Lágrimas/química
Lágrimas/metabolismo
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Cytokines)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170929
[Lr] Data última revisão:
170929
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170928
[St] Status:MEDLINE


  6 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28860044
[Au] Autor:Labowsky MT; Stinnett SS; Liss J; Daluvoy M; Hall RP; Shieh C
[Ad] Endereço:Duke University School of Medicine, Durham, North Carolina. Electronic address: marytlabowsky@gmail.com.
[Ti] Título:Clinical Implications of Direct Immunofluorescence Findings in Patients With Ocular Mucous Membrane Pemphigoid.
[So] Source:Am J Ophthalmol;183:48-55, 2017 Nov.
[Is] ISSN:1879-1891
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: To examine the clinical implications of positive or negative direct immunofluorescence biopsies (DIF) in patients with clinically typical ocular mucous membrane pemphigoid (MMP). DESIGN: Retrospective cohort study. METHODS: The study population was patients with clinically typical ocular MMP disease with documented DIF results who were followed for at least 1 year at the Duke University multidisciplinary ocular MMP clinic. Data were collected by chart review and included patient demographics, clinical examination findings, and history of autoimmune disease and/or malignancy, as well as topical, systemic, and surgical treatments received. Main outcome measures included MMP Disease Area Index, Foster stages, proportion legally blind, duration of follow-up, and use of systemic immunosuppression and ocular procedures in treatment. RESULTS: In multivariable analysis restricted to 55 patients, patients with negative and positive biopsies were similar in the outcome measures; however, positive-biopsy patients were more likely to be treated with systemic immunosuppression and were followed for longer at our clinic. Patients with isolated ocular disease were also more likely to have negative biopsies compared to those who also had extraocular disease. Patients who had conjunctival biopsies were more likely to have a negative direct immunofluorescence result than patients with biopsies from other sites. CONCLUSIONS: We encourage clinicians and patients to consider treatment with systemic immunosuppression even in the absence of diagnosis confirmation by DIF. Furthermore, this study supports current standard of care to pursue a nonocular biopsy of normal-appearing, perilesional skin or oral mucosa when possible.
[Mh] Termos MeSH primário: Autoanticorpos/análise
Túnica Conjuntiva/patologia
Doenças da Túnica Conjuntiva/diagnóstico
Técnica Direta de Fluorescência para Anticorpo/métodos
Penfigoide Mucomembranoso Benigno/diagnóstico
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Autoanticorpos/imunologia
Membrana Basal/patologia
Biópsia
Doenças da Túnica Conjuntiva/imunologia
Feminino
Seguimentos
Seres Humanos
Masculino
Meia-Idade
Penfigoide Mucomembranoso Benigno/imunologia
Reprodutibilidade dos Testes
Estudos Retrospectivos
Índice de Gravidade de Doença
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Autoantibodies)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171102
[Lr] Data última revisão:
171102
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170902
[St] Status:MEDLINE


  7 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28813228
[Au] Autor:Braun R; Holler E
[Ad] Endereço:Universitätsklinikum Regensburg, Regensburg, Germany regine.braun@ukr.de.
[Ti] Título:Acute Ocular Graft-versus-Host Disease.
[So] Source:N Engl J Med;377(7):676, 2017 Aug 17.
[Is] ISSN:1533-4406
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Doenças da Túnica Conjuntiva/patologia
Doença Enxerto-Hospedeiro/patologia
Transplante de Células-Tronco Hematopoéticas/efeitos adversos
[Mh] Termos MeSH secundário: Doença Aguda
Doenças da Túnica Conjuntiva/etiologia
Seres Humanos
Leucemia Mieloide Aguda/terapia
Masculino
Membranas
Adulto Jovem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170830
[Lr] Data última revisão:
170830
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170817
[St] Status:MEDLINE
[do] DOI:10.1056/NEJMicm1701185


  8 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28724821
[Au] Autor:Ojha PR; Deshpande AH; Gargade CB; Nigam JS
[Ad] Endereço:Department of Pathology, Andaman and Nicobar Islands Institute of Medical Sciences, Port Blair, Andaman and Nicobar Islands, India.
[Ti] Título:Epipalpebral conjunctival chondroid choristoma: Interesting developmental anomaly presenting in an adult.
[So] Source:Indian J Ophthalmol;65(7):613-614, 2017 Jul.
[Is] ISSN:1998-3689
[Cp] País de publicação:India
[La] Idioma:eng
[Ab] Resumo:Ocular choristomas are uncommon lesions chiefly presenting in children. Choristomas may contain dermal and epidermal components, muscle, cartilage, bone, etc. They are usually seen in epibulbar conjunctiva, but epipalpebral location is uncommon. We present a case of epipalpebral chondroid choristoma presenting in an adult patient.
[Mh] Termos MeSH primário: Cartilagem
Coristoma/diagnóstico
Doenças da Túnica Conjuntiva/diagnóstico
[Mh] Termos MeSH secundário: Adulto
Biópsia
Diagnóstico Diferencial
Seres Humanos
Masculino
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171109
[Lr] Data última revisão:
171109
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170721
[St] Status:MEDLINE
[do] DOI:10.4103/ijo.IJO_39_17


  9 / 2873 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28605812
[Au] Autor:Brown KD; Shah MH; Liu GS; Chan EC; Crowston JG; Peshavariya HM
[Ad] Endereço:Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Victoria, Australia 2Ophthalmology, University of Melbourne, Department of Surgery, Melbourne, Australia.
[Ti] Título:Transforming Growth Factor ß1-Induced NADPH Oxidase-4 Expression and Fibrotic Response in Conjunctival Fibroblasts.
[So] Source:Invest Ophthalmol Vis Sci;58(7):3011-3017, 2017 Jun 01.
[Is] ISSN:1552-5783
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Purpose: Fibrotic scarring after ocular surgeries and chemical burn injuries can impede clarity of the cornea and cause vision impairment. Transforming growth factor ß (TGFß) signaling pathway is known to mediate fibrotic scarring, and NADPH oxidase-derived reactive oxygen species has been shown to be an effector molecule that facilitates TGFß1-mediated responses. The present study explores the expression profile and functional importance of NADPH oxidase (Nox) in conjunctival fibroblasts. In addition, the effect of curcumin on the TGFß1-induced NADPH oxidase expression and collagen synthesis was also investigated. Methods: The mRNA expression of Nox isoforms in rabbit conjunctival fibroblasts was measured by real-time PCR. The production of hydrogen peroxide (H2O2) and total collagen by these cells was measured by Amplex Red assay and Picro-Sirius red assay, respectively. Nox4 was knocked down by adenovirus-mediated siRNA targeting Nox4 (Adv-Nox4i). Results: We describe for the first time that conjunctival fibroblasts express mRNA encoding for Nox2, Nox3, Nox4, and Nox5. TGFß1 was found to induce Nox4 mRNA expression and total collagen release by these cells (P < 0.05; n = 4), and both responses are blocked by Smad3 inhibitor SIS3. Suppressing Nox4 gene transcription with Adv-Nox4i completely attenuated TGFß1-stimulated H2O2 release and collagen production by conjunctival fibroblasts (P < 0.05; n = 4-6). Similarly, curcumin also inhibited TGFß1-induced Smad3 phosphorylation, Nox4-derived H2O2 production, and total collagen synthesis by conjunctival fibroblasts (P < 0.05; n = 4-6). Conclusions: The present study suggests that TGFß1-mediated production of collagen by conjunctival fibroblasts involves Nox4-derived H2O2 pathway and this effect of Nox4 is abrogated by curcumin. This mechanism might be exploited to prevent fibrotic scarring after surgeries and chemical burn injuries in the eye.
[Mh] Termos MeSH primário: Túnica Conjuntiva/metabolismo
Doenças da Túnica Conjuntiva/genética
Regulação da Expressão Gênica
NADPH Oxidases/genética
RNA Mensageiro/genética
Fator de Crescimento Transformador beta1/farmacologia
[Mh] Termos MeSH secundário: Animais
Western Blotting
Células Cultivadas
Túnica Conjuntiva/efeitos dos fármacos
Túnica Conjuntiva/patologia
Doenças da Túnica Conjuntiva/tratamento farmacológico
Doenças da Túnica Conjuntiva/metabolismo
Fibroblastos/metabolismo
Fibrose/tratamento farmacológico
Fibrose/genética
Fibrose/metabolismo
NADPH Oxidase 4
NADPH Oxidases/biossíntese
Coelhos
Reação em Cadeia da Polimerase em Tempo Real
Transdução de Sinais
Espectrofotometria
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (RNA, Messenger); 0 (Transforming Growth Factor beta1); EC 1.6.3.- (NADPH Oxidase 4); EC 1.6.3.- (NADPH Oxidases); EC 1.6.3.- (NOX4 protein, human)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:171116
[Lr] Data última revisão:
171116
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170613
[St] Status:MEDLINE
[do] DOI:10.1167/iovs.16-20633


  10 / 2873 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28576214
[Au] Autor:Santiago E; Yang Y; Conlon R; Compan J; Baig K; Ziai S
[Ad] Endereço:University of Ottawa Eye Institute, Ottawa, Ont.
[Ti] Título:Surgical techniques for the treatment of conjunctivochalasis: paste-pinch-cut conjunctivoplasty versus thermal cautery conjunctivoplasty.
[So] Source:Can J Ophthalmol;52(3):308-312, 2017 Jun.
[Is] ISSN:1715-3360
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: The aim of this study was to evaluate the outcomes of paste-pinch-cut conjunctivoplasty and cautery conjunctivoplasty for the treatment of symptomatic conjunctivochalasis. DESIGN: This was a prospective cohort study. PARTICIPANTS: Sixteen patients (32 eyes) with bilateral conjunctivochalasis that was symptomatic after medical therapy were enrolled in the study. METHODS: This was a single-centre, contralateral eye, prospective study. Paste-pinch-cut conjunctivoplasty was performed in the left eye, and thermal cautery conjunctivoplasty was performed in the right eye. The outcomes of each procedure were compared preoperatively and at the 1-month follow-up by using the Canadian Dry Eye Assessment (CDEA) scoring system, standard conjunctivochalasis grading, and corneal staining. Intraoperative discomfort and immediate postoperative discomfort were assessed by using a 10-point scale. RESULTS: The mean age of patients was 72.4 ± 8.67 years. Conjunctival redundancy was absent in 14 of 16 patients postoperatively. The mean CDEA score improved after both procedures (7.1 ± 2.8 preoperatively versus 4.5 ± 0.78 at the 1-month follow-up for cautery conjunctivoplasty, 7.4 ± 2.5 versus 4.9 ± 3.1 for paste-pinch-cut conjunctivoplasty). This improvement was statistically significant in the cautery conjunctivoplasty group (p = 0.012). Mean intraoperative discomfort was 2.6 ± 2.1 with the use of paste-pinch-cut conjunctivoplasty and 3.5 ± 3.2 with the use of cautery conjunctivoplasty; however, the difference was not statistically significant. No intraoperative or postoperative complications were observed with either technique. CONCLUSIONS: Paste-pinch-cut and thermal cautery conjunctivoplasty are both safe and effective surgical treatments for the repair of conjunctivochalasis, with patients reporting greater improvement in symptoms after the cautery technique.
[Mh] Termos MeSH primário: Cauterização/métodos
Túnica Conjuntiva/cirurgia
Doenças da Túnica Conjuntiva/cirurgia
Procedimentos Cirúrgicos Oftalmológicos/métodos
Procedimentos Cirúrgicos Reconstrutivos/métodos
[Mh] Termos MeSH secundário: Idoso
Feminino
Seguimentos
Seres Humanos
Masculino
Estudos Prospectivos
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170919
[Lr] Data última revisão:
170919
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170604
[St] Status:MEDLINE



página 1 de 288 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde